Closed System Transfer Devices Market - Global Forecast to 2030
商品番号 : SMB-5852
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
| ページ数 | 290 |
| 図表数 | 338 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、閉鎖式薬物移送システム（CSTD）市場を評価し、閉鎖機構、タイプ、コンポーネント、技術、エンドユーザー、地域など、様々なセグメントに基づいて市場規模と将来の成長可能性を予測しています。また、この市場における主要企業の競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略も掲載しています。
The closed system transfer devices (CSTDs) market is projected to reach USD 2.09 billion by 2030, from USD 1.49 billion in 2025, at a CAGR of 7.0%.
閉鎖式薬物移送システム（CSTD）市場は、2025年の14億9,000万米ドルから2030年には7.0%のCAGRで成長し、20億9,000万米ドルに達すると予測されています。
With the increased consciousness and interest in the safety of healthcare workers, there is an increasing market demand for closed system transfer devices. Healthcare institutions are spending more on these devices to advance safety procedures and shield their workers against the dangers of working with unsafe drugs. This rising demand will, therefore, boost the growth of the closed system transfer devices market as healthcare facilities prioritize taking safety measures to secure their workforce.
医療従事者の安全に対する意識と関心が高まるにつれ、閉鎖式移送機器の市場需要が高まっています。医療機関は、安全手順の向上と、危険な薬剤を扱う際の危険から医療従事者を守るため、これらの機器への投資を増やしています。医療施設が従業員の安全確保のために安全対策を優先する中、この需要の高まりは閉鎖式移送機器市場の成長を後押しするでしょう。
Depending on the closing mechanism, the color-to-color alignment system segmented shall increase at the highest CAGR in the closed system transfer devices market.
On the basis of components, the vial access segment held the largest market share of the closed system transfer devices market. Vial access components have a crucial function in reducing the risk of needlestick injury among healthcare professionals and avoiding drug contamination while transferring. Additionally, ease of handling enables quick medication preparation and minimizes the risk of errors related to open systems. Thus, addressing safety and efficiency requirements, the vial access components segment is likely to drive the market.
Based on the end-user segment, the hospitals & clinics subsegment is dominated the closed system transfer devices market. In contrast to other medical facilities, hospitals and clinics have a bigger budget for medical equipment. This gives them the capability to spend on the newest CSTD technology while keeping abreast with regulations and best practices. Further, hospitals and clinics are under more rigid regulations on handling medication and employee protection. CSTDs assist them in fulfilling these needs by reducing the risk of exposure to dangerous drugs and avoiding medication errors.
North America is expected to account for the largest share of the closed system transfer devices market during the forecast period. This is due to the increased awareness by healthcare professionals towards the significance of the safe handling of drugs as well as a well-established infrastructure of healthcare and rigorous regulatory requirements. The region has been leading in the adoption of sophisticated medical technology to improve patient care and safety.
A breakdown of the primary participants (supply-side) for the closed system transfer devices market referred to for this report is provided below:
- By Company Type: Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
- By Designation: C-level: 39%, Director Level: 33%, and Others: 28%
- By Region: North America: 64%, Europe: 17%, Asia Pacific: 7%, Latin America: 6%, Middle East & Africa: 6%
Prominent players in the closed system transfer device market are BD (US), ICU Medical, Inc. (US), EQUASHIELD (US), JMS Co. Ltd. (Japan), Baxter (US), B Braun Melsungen AG (Germany), West Pharmaceuticals Services, Inc. (US) and Terumo Corporation (Japan).
Research Coverage
The report evaluates the closed system transfer devices market and estimates the market size and future growth potential based on various segments, including closing mechanism, type, component, technology, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will assist the market leaders/new entrants with data on the nearest approximations of the revenue numbers for the overall closed system transfer devices market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights to better place their businesses and make appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.
This report provides insights into the following points:
Analysis of key drivers (growing incidence of cancer and subsequent use of chemotherapy, Increasing regulatory approvals for oncology therapeutics, rising awareness about risks associated with handling antineoplastic drugs, stringent regulatory guidelines for handling hazardous medication), restraints (high implementation costs and limited reimbursements, Inconsistent regulatory compliance), opportunities (growth potential across therapeutic applications, rising healthcare expenditure in emerging economies) and challenges (impact of closed system transfer devices on drug quality, low awareness and poor implementation of protective measures)
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global closed system transfer devices market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by closing mechanism, type, component, technology, end user, and region
- Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global closed system transfer devices market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global closed system transfer devices market
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 29
1.3.2 INCLUSIONS AND EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
2.2 MARKET SIZE ESTIMATION 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
2.4 MARKET SHARE ESTIMATION 46
2.5 RESEARCH ASSUMPTIONS 46
2.6 RESEARCH LIMITATIONS 47
2.6.1 SCOPE-RELATED LIMITATIONS 47
2.6.2 METHODOLOGY-RELATED LIMITATIONS 47
2.7 RISK ASSESSMENT 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 53
4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW 53
4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY AND COUNTRY, 2024 54
4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX 55
4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 55
4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing incidence of cancer and subsequent use of chemotherapy 58
5.2.1.2 Increasing regulatory approvals for oncology therapeutics 58
5.2.1.3 Rising awareness about risks associated with handling antineoplastic drugs 59
5.2.1.4 Stringent regulatory guidelines for handling hazardous medication 60
5.2.2 RESTRAINTS 61
5.2.2.1 High implementation costs and limited reimbursements 61
5.2.2.2 Inconsistent regulatory compliance 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Growth potential across therapeutic applications 62
5.2.3.2 Rising healthcare expenditure in emerging economies 63
5.2.4 CHALLENGES 63
5.2.4.1 Impact of closed system transfer devices on drug quality 63
5.2.4.2 Low awareness and poor implementation of protective measures 64
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 66
5.4 PRICING ANALYSIS 67
5.4.1 AVERAGE SELLING PRICE TREND, BY COMPONENT 67
5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 68
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 68
5.5 VALUE CHAIN ANALYSIS 69
5.5.1 RESEARCH & PRODUCT DEVELOPMENT 70
5.5.2 MATERIAL COMPONENT PROCUREMENT AND MANUFACTURING 70
5.5.3 MARKETING & SALES, SHIPMENT, AND AFTERSALES SERVICES 70
5.6 SUPPLY CHAIN ANALYSIS 71
5.7 ECOSYSTEM ANALYSIS 72
5.8 INVESTMENT AND FUNDING SCENARIO 74
5.9 TECHNOLOGY ANALYSIS 75
5.9.1 KEY TECHNOLOGIES 75
5.9.1.1 Needle-free systems 75
5.9.2 COMPLEMENTARY TECHNOLOGIES 76
5.9.2.1 Integration of sensors 76
5.9.3 ADJACENT TECHNOLOGIES 76
5.9.3.1 Advancements in containments 76
5.10 INDUSTRY TRENDS 77
5.10.1 INTEGRATION OF FILTERS IN CLOSED SYSTEM TRANSFER DEVICES 77
5.10.2 AUTOMATION OF TRANSFER PROCESSES 77
5.10.3 ADVANCED MATERIALS FOR DURABILITY AND COMPATIBILITY WITH COMPLEX DRUG FORMULATIONS 78
5.11 PATENT ANALYSIS 79
5.12 TRADE DATA ANALYSIS 81
5.12.1 IMPORT DATA 81
5.12.2 EXPORT DATA 83
5.13 KEY CONFERENCES AND EVENTS, 2025–2026 85
5.14 CASE STUDY ANALYSIS 86
5.14.1 CASE STUDY 1: EXTENSION OF BEYOND-USE DATE OF SINGLE-DOSE VIALS AT MOUNT SINAI HOSPITAL 86
5.14.2 CASE STUDY 2: ENHANCED SAFETY AND EFFICIENCY OF DRUG COMPOUNDING AT NEBRASKA METHODIST HOSPITAL 86
5.14.3 CASE STUDY 3: PREVENTION OF MICROBIAL CONTAMINATION DURING SIMULATED WORST-CASE SCENARIOS 86
5.15 REGULATORY LANDSCAPE 87
5.15.1 REGULATORY STANDARDS AND APPROVALS 87
5.15.1.1 US 87
5.15.1.1.1 USP <800> Regulations 87
5.15.1.1.2 National Institute for Occupational Safety and Health 87
5.15.1.1.3 American Society of Health-System Pharmacists 89
5.15.1.1.4 International Society of Oncology Pharmacy Practitioners 90
5.15.1.2 European Union 90
5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
5.16 PORTER’S FIVE FORCES ANALYSIS 94
5.16.1 BARGAINING POWER OF SUPPLIERS 95
5.16.2 BARGAINING POWER OF BUYERS 95
5.16.3 THREAT OF NEW ENTRANTS 95
5.16.4 THREAT OF SUBSTITUTES 96
5.16.5 INTENSITY OF COMPETITIVE RIVALRY 96
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 97
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
5.17.2 BUYING CRITERIA 98
5.18 UNMET NEEDS/END-USER EXPECTATIONS 98
5.19 IMPACT OF GEN AI ON CLOSED SYSTEM TRANSFER DEVICES MARKET 99
5.19.1 INTRODUCTION 99
5.19.2 MARKET POTENTIAL OF AI IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET 99
5.19.3 AI USE CASES 100
5.19.4 KEY COMPANIES IMPLEMENTING AI 100
5.19.5 FUTURE OF GENERATIVE AI IN CLOSED SYSTEM TRANSFER DEVICES MARKET 101
5.20 IMPACT OF US TARIFF REGULATION ON CLOSED SYSTEM TRANSFER DEVICES MARKET 101
5.20.1 NORTH AMERICA 101
5.20.2 EUROPE 101
5.20.3 ASIA PACIFIC 102
5.20.4 LATIN AMERICA 102
5.20.5 MIDDLE EAST & AFRICA 102
6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM 103
6.1 INTRODUCTION 104
6.2 LUER LOCK SYSTEMS 106
6.2.1 GROWING PREVALENCE OF INJECTABLE DRUGS TO PROPEL MARKET 106
6.3 PUSH-TO-TURN SYSTEMS 107
6.3.1 INCREASING FOCUS ON COMPLYING WITH REGULATIONS AND GUIDELINES FOR SAFE HANDLING OF DRUGS TO AID GROWTH 107
6.4 CLICK-TO-LOCK SYSTEMS 109
6.4.1 LOW IMPLEMENTATION COST TO CONTRIBUTE TO GROWTH 109
6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS 110
6.5.1 GROWING FOCUS ON CURBING RISK OF MEDICATION ERRORS TO FUEL MARKET 110
7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE 112
7.1 INTRODUCTION 113
7.2 MEMBRANE-TO-MEMBRANE SYSTEMS 114
7.2.1 INCREASING FOCUS ON SAFEGUARDING HEALTH AND WELL-BEING OF HEALTHCARE PROVIDERS TO EXPEDITE GROWTH 114
7.3 NEEDLELESS SYSTEMS 116
7.3.1 EVOLVING MEDICAL DEVICE TECHNOLOGY LANDSCAPE TO STIMULATE GROWTH 116
8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT 118
8.1 INTRODUCTION 119
8.2 VIAL ACCESS COMPONENTS 120
8.2.1 GROWING CONCERNS SURROUNDING HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE MARKET 120
8.3 MALE LUERS 123
8.3.1 NEED TO PREVENT AIR EMBOLISM AND PRESERVE INTEGRITY OF INTRAVENOUS SYSTEMS TO PROMOTE GROWTH 123
8.4 BAG SPIKES 125
8.4.1 GROWING FOCUS ON ENHANCED SAFETY, EFFICIENCY, AND PRECISION IN HANDLING AND ADMINISTRATING HAZARDOUS DRUGS TO BOOST MARKET 125
8.5 FEMALE COMPONENTS 127
8.5.1 NEED TO PREVENT CONTAMINATION OF DRUGS AND EQUIPMENT TO ENCOURAGE GROWTH 127
8.6 OTHER COMPONENTS 130
9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY 132
9.1 INTRODUCTION 133
9.2 DIAPHRAGM-BASED DEVICES 134
9.2.1 INCREASING USE OF DIAPHRAGM-BASED DEVICES IN CHEMOTHERAPY AND OTHER ONCOLOGY TREATMENTS TO FOSTER GROWTH 134
9.3 COMPARTMENTALIZED DEVICES 136
9.3.1 NEED TO MAINTAIN INTEGRITY OF MEDICATIONS DURING TRANSFER TO SUSTAIN GROWTH 136
9.4 AIR CLEANING/FILTRATION DEVICES 138
9.4.1 NEED FOR CLEAN AND STERILE ENVIRONMENT WITHIN PHARMACEUTICAL AND HEALTHCARE FACILITIES TO FACILITATE GROWTH 138
10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER 140
10.1 INTRODUCTION 141
10.2 HOSPITALS & CLINICS 141
10.2.1 GROWING FOCUS ON ENHANCED STAFF AND PATIENT SAFETY IN HEALTHCARE SETTINGS TO BOOST MARKET 141
10.3 ONCOLOGY CENTERS 142
10.3.1 NEED TO MINIMIZE RISK OF OCCUPATIONAL EXPOSURE TO AUGMENT GROWTH 142
10.4 OTHER END USERS 144
11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION 146
11.1 INTRODUCTION 147
11.2 NORTH AMERICA 148
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148
11.2.2 US 152
11.2.2.1 Rising focus on best practice recommendations and mandates for healthcare workers to aid growth 152
11.2.3 CANADA 154
11.2.3.1 Increasing demand for antineoplastic drugs to assist growth 154
11.3 EUROPE 157
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157
11.3.2 GERMANY 160
11.3.2.1 Growing emphasis on healthcare protocols to propel market 160
11.3.3 UK 162
11.3.3.1 Strict guidelines for handling hazardous drugs to promote growth 162
11.3.4 FRANCE 165
11.3.4.1 High healthcare expenditure to accelerate growth 165
11.3.5 SPAIN 167
11.3.5.1 Increasing incidence of cancer to favor growth 167
11.3.6 ITALY 169
11.3.6.1 Rising geriatric population and subsequent prevalence of chronic diseases to aid growth 169
11.3.7 REST OF EUROPE 172
11.4 ASIA PACIFIC 174
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 174
11.4.2 JAPAN 178
11.4.2.1 Established healthcare system and rising geriatric population to drive market 178
11.4.3 CHINA 180
11.4.3.1 Large target patient population to stimulate growth 180
11.4.4 INDIA 183
11.4.4.1 Rising adoption of chemotherapy procedures to facilitate growth 183
11.4.5 AUSTRALIA AND NEW ZEALAND 185
11.4.5.1 Rising incidence of chronic diseases to speed up growth 185
11.4.6 SOUTH KOREA 187
11.4.6.1 Shift to aging demography to spur growth 187
11.4.7 REST OF ASIA PACIFIC 190
11.5 LATIN AMERICA 192
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 192
11.5.2 BRAZIL 194
11.5.2.1 Booming healthcare and pharmaceutical sectors to amplify growth 194
11.5.3 MEXICO 197
11.5.3.1 Rising initiatives on universal healthcare coverage to support growth 197
11.5.4 COLOMBIA 199
11.5.4.1 Growing prioritization of patient and worker safety to bolster growth 199
11.5.5 REST OF LATIN AMERICA 201
11.6 MIDDLE EAST & AFRICA 204
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204
11.6.2 GCC COUNTRIES 206
11.6.2.1 Higher disposable incomes to expedite growth 206
11.6.3 REST OF MIDDLE EAST & AFRICA 209
12 COMPETITIVE LANDSCAPE 212
12.1 OVERVIEW 212
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 212
12.3 REVENUE ANALYSIS, 2020–2024 215
12.4 MARKET SHARE ANALYSIS, 2024 216
12.5 R&D ASSESSMENT OF KEY PLAYERS 217
12.6 COMPANY VALUATION AND FINANCIAL METRICES 218
12.7 BRAND/PRODUCT COMPARISON 219
12.7.1.1 BD 220
12.7.1.2 ICU Medical, Inc. 220
12.7.1.3 B. Braun Melsungen AG 220
12.7.1.4 JMS Co. Ltd. 220
12.7.1.5 Baxter 220
12.7.1.6 EQUASHIELD 220
12.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221
12.8.1 STARS 221
12.8.2 EMERGING LEADERS 221
12.8.3 PERVASIVE PLAYERS 221
12.8.4 PARTICIPANTS 221
12.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223
12.8.5.1 Company footprint 223
12.8.5.2 Region footprint 224
12.8.5.3 Closing mechanism footprint 225
12.8.5.4 Type footprint 226
12.8.5.5 Component footprint 227
12.8.5.6 Technology footprint 228
12.8.5.7 End-user footprint 229
12.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 230
12.9.1 PROGRESSIVE COMPANIES 230
12.9.2 RESPONSIVE COMPANIES 230
12.9.3 DYNAMIC COMPANIES 230
12.9.4 STARTING BLOCKS 230
12.9.5 COMPETITIVE BENCHMARKING 232
12.9.5.1 Detailed list of key startups/SMEs 232
12.9.5.2 Competitive benchmarking of key startups/SMEs 233
12.10 COMPETITIVE SCENARIO 233
12.10.1 PRODUCT LAUNCHES AND APPROVALS 233
12.10.2 DEALS 234
12.10.3 EXPANSIONS 235
13 COMPANY PROFILES 236
13.1 KEY PLAYERS 236
13.1.1 BD 236
13.1.1.1 Business overview 236
13.1.1.2 Products offered 237
13.1.1.3 Recent developments 238
13.1.1.3.1 Deals 238
13.1.1.4 MnM view 239
13.1.1.4.1 Right to win 239
13.1.1.4.2 Strategic choices 239
13.1.1.4.3 Weaknesses and competitive threats 239
13.1.2 ICU MEDICAL, INC. 240
13.1.2.1 Business overview 240
13.1.2.2 Products offered 242
13.1.2.3 Recent developments 243
13.1.2.3.1 Deals 243
13.1.2.4 MnM view 243
13.1.2.4.1 Right to win 243
13.1.2.4.2 Strategic choices 243
13.1.2.4.3 Weaknesses and competitive threats 243
13.1.3 B. BRAUN MELSUNGEN AG 244
13.1.3.1 Business overview 244
13.1.3.2 Products offered 246
13.1.3.3 Recent developments 246
13.1.3.3.1 Product launches and approvals 246
13.1.3.3.2 Expansions 247
13.1.3.4 MnM view 247
13.1.3.4.1 Right to win 247
13.1.3.4.2 Strategic choices 247
13.1.3.4.3 Weaknesses and competitive threats 247
13.1.4 JMS CO. LTD. 248
13.1.4.1 Business overview 248
13.1.4.2 Products offered 249
13.1.4.3 MnM view 249
13.1.4.3.1 Right to win 249
13.1.4.3.2 Strategic choices 249
13.1.4.3.3 Weaknesses and competitive threats 249
13.1.5 BAXTER 250
13.1.5.1 Business overview 250
13.1.5.2 Products offered 251
13.1.5.3 Recent developments 252
13.1.5.3.1 Deals 252
13.1.5.4 MnM view 252
13.1.5.4.1 Right to win 252
13.1.5.4.2 Strategic choices 252
13.1.5.4.3 Weaknesses and competitive threats 252
13.1.6 WEST PHARMACEUTICAL SERVICES, INC. 253
13.1.6.1 Business overview 253
13.1.6.2 Products offered 255
13.1.6.3 Recent developments 255
13.1.6.3.1 Expansions 255
13.1.7 TERUMO CORPORATION 256
13.1.7.1 Business overview 256
13.1.7.2 Products offered 257
13.1.7.3 Recent developments 258
13.1.7.3.1 Expansions 258
13.1.8 CARDINAL HEALTH 259
13.1.8.1 Business overview 259
13.1.8.2 Products offered 260
13.1.9 EQUASHIELD 261
13.1.9.1 Business overview 261
13.1.9.2 Products offered 261
13.1.9.3 Recent developments 262
13.1.9.3.1 Product launches and approvals 262
13.1.9.3.2 Deals 262
13.1.10 SIMPLIVIA HEALTHCARE LTD. 263
13.1.10.1 Business overview 263
13.1.10.2 Products offered 263
13.1.10.3 Recent developments 264
13.1.10.3.1 Deals 264
13.1.11 YUKON MEDICAL 265
13.1.11.1 Business overview 265
13.1.11.2 Products offered 265
13.1.12 CODAN MEDIZINISCHE GERÄTE GMBH 266
13.1.12.1 Business overview 266
13.1.12.2 Products offered 267
13.1.13 VYGON 268
13.1.13.1 Business overview 268
13.1.13.2 Products offered 268
13.1.13.3 Recent developments 269
13.1.13.3.1 Deals 269
13.1.14 ELCAM MEDICAL 270
13.1.14.1 Business overview 270
13.1.14.2 Products offered 270
13.1.15 PRACTIVET, INC. 271
13.1.15.1 Business overview 271
13.1.15.2 Products offered 271
13.2 OTHER COMPANIES 272
13.2.1 CARAGEN 272
13.2.2 CORVIDA MEDICAL 273
13.2.3 VICTUS 274
13.2.4 EPIC SYSTEMS CORPORATIONS 275
13.2.5 ERASER MEDICAL 276
13.2.6 NEEDLELESS CORPORATION 277
13.2.7 AMSINO INTERNATIONAL, INC. 278
13.2.8 INSUNG MEDICAL CO., LTD. 279
13.2.9 ADVCARE MEDICAL, INC. 280
13.2.10 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD. 280
14 APPENDIX 281
14.1 DISCUSSION GUIDE 281
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286
14.3 CUSTOMIZATION OPTIONS 288
14.4 RELATED REPORTS 288
14.5 AUTHOR DETAILS 289
LIST OF TABLES
TABLE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET: INCLUSIONS AND EXCLUSIONS 30
TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021–2024 31
TABLE 3 CLOSED SYSTEM TRANSFER DEVICES MARKET: RISK ASSESSMENT ANALYSIS 47
TABLE 4 NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING CLOSED SYSTEM TRANSFER DEVICES FOR MEDICATION HANDLING, BY COUNTRY 60
TABLE 5 CLOSED SYSTEM TRANSFER DEVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 65
TABLE 6 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES,
BY COMPONENT, 2022−2024 67
TABLE 7 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES,
BY KEY PLAYER, 2022−2024 68
TABLE 8 AVERAGE SELLING TREND OF CLOSED SYSTEM TRANSFER COMPONENTS,
BY REGION, 2022−2024 69
TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: ROLE OF COMPANIES
IN ECOSYSTEM 73
TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2022−2024 80
TABLE 11 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020–2024 (USD THOUSAND) 82
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 84
TABLE 13 CLOSED SYSTEM TRANSFER DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 85
TABLE 14 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: CLASSIFICATION OF HAZARDOUS DRUGS 88
TABLE 15 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND <USP 800> REQUIREMENTS 88
TABLE 16 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH AND AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS: DEFINITIONS FOR HAZARDOUS DRUGS 90
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 22 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 94
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES (%) 97
TABLE 24 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES 98
TABLE 25 KEY COMPANIES IMPLEMENTING AI 100
TABLE 26 CLOSING MECHANISMS AVAILABLE IN CLOSED SYSTEM TRANSFER DEVICES 104
TABLE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM,
2023–2030 (USD MILLION) 105
TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR LUER LOCK SYSTEMS,
BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR PUSH-TO-TURN SYSTEMS,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR CLICK-TO-LOCK SYSTEMS,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 31 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR COLOR-TO-COLOR ALIGNMENT SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 113
TABLE 33 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS 114
TABLE 34 MEMBRANE-TO-MEMBRANE CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 35 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS 116
TABLE 36 NEEDLELESS CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 119
TABLE 38 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 120
TABLE 39 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 40 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY REGION, 2023–2030 (THOUSAND UNITS) 122
TABLE 41 MALE LUERS FOR CLOSED SYSTEM TRANSFER DEVICES 123
TABLE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS,
BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 43 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS,
BY REGION, 2023–2030 (THOUSAND UNITS) 124
TABLE 44 BAG SPIKE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 125
TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES,
BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES,
BY REGION, 2021–2029 (THOUSAND UNITS) 127
TABLE 47 FEMALE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 128
TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 49 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS,
BY REGION, 2023–2030 (THOUSAND UNITS) 129
TABLE 50 OTHER COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES 130
TABLE 51 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 52 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 133
TABLE 53 DIAPHRAGM-BASED DEVICES AVAILABLE IN MARKET 134
TABLE 54 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 55 COMPARTMENTALIZED DEVICES AVAILABLE IN MARKET 136
TABLE 56 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 57 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN MARKET 138
TABLE 58 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 59 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 141
TABLE 60 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 61 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS,
BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 62 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 63 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 64 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 65 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 150
TABLE 66 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 67 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 151
TABLE 68 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 151
TABLE 69 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 151
TABLE 70 US: KEY MACROECONOMIC INDICATORS 152
TABLE 71 US: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 153
TABLE 72 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 73 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 153
TABLE 74 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 154
TABLE 75 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 76 CANADA: KEY MACROECONOMIC INDICATORS 155
TABLE 77 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 155
TABLE 78 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 79 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 156
TABLE 80 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 156
TABLE 81 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 156
TABLE 82 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 83 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 158
TABLE 84 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 85 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 159
TABLE 86 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 159
TABLE 87 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 160
TABLE 88 GERMANY: KEY MACROECONOMIC INDICATORS 160
TABLE 89 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 161
TABLE 90 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 161
TABLE 91 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 161
TABLE 92 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 162
TABLE 93 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 162
TABLE 94 UK: KEY MACROECONOMIC INDICATORS 163
TABLE 95 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 163
TABLE 96 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 97 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 164
TABLE 98 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 164
TABLE 99 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 164
TABLE 100 FRANCE: KEY MACROECONOMIC INDICATORS 165
TABLE 101 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 165
TABLE 102 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 166
TABLE 103 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 166
TABLE 104 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 166
TABLE 105 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 167
TABLE 106 SPAIN: KEY MACROECONOMIC INDICATORS 167
TABLE 107 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 168
TABLE 108 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 109 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 168
TABLE 110 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 169
TABLE 111 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 169
TABLE 112 ITALY: KEY MACROECONOMIC INDICATORS 170
TABLE 113 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 170
TABLE 114 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 115 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 171
TABLE 116 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 171
TABLE 117 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 171
TABLE 118 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 172
TABLE 119 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 120 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 173
TABLE 121 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 173
TABLE 122 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 173
TABLE 123 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 124 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 176
TABLE 125 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 126 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 177
TABLE 127 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 177
TABLE 128 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 178
TABLE 129 JAPAN: KEY MACROECONOMIC INDICATORS 178
TABLE 130 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 179
TABLE 131 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 132 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 179
TABLE 133 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 180
TABLE 134 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 180
TABLE 135 CHINA: KEY MACROECONOMIC INDICATORS 181
TABLE 136 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 181
TABLE 137 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 138 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 182
TABLE 139 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 182
TABLE 140 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 182
TABLE 141 INDIA: KEY MACROECONOMIC INDICATORS 183
TABLE 142 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 183
TABLE 143 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 144 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 184
TABLE 145 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 184
TABLE 146 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 185
TABLE 147 AUSTRALIA: KEY MACROECONOMIC INDICATORS 185
TABLE 148 NEW ZEALAND: KEY MACROECONOMIC INDICATORS 185
TABLE 149 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 186
TABLE 150 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 151 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 186
TABLE 152 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 187
TABLE 153 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 187
TABLE 154 SOUTH KOREA: KEY MACROECONOMIC INDICATORS 188
TABLE 155 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 188
TABLE 156 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 157 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 189
TABLE 158 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 189
TABLE 159 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 189
TABLE 160 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 190
TABLE 161 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 162 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 191
TABLE 163 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 191
TABLE 164 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 191
TABLE 165 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 166 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 193
TABLE 167 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 168 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 193
TABLE 169 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 194
TABLE 170 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 194
TABLE 171 BRAZIL: KEY MACROECONOMIC INDICATORS 195
TABLE 172 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 195
TABLE 173 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 174 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 196
TABLE 175 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 196
TABLE 176 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 196
TABLE 177 MEXICO: KEY MACROECONOMIC INDICATORS 197
TABLE 178 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 197
TABLE 179 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 180 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 198
TABLE 181 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 198
TABLE 182 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 199
TABLE 183 COLOMBIA: KEY MACROECONOMIC INDICATORS 199
TABLE 184 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 200
TABLE 185 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 186 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 200
TABLE 187 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 201
TABLE 188 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 201
TABLE 189 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 202
TABLE 190 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 191 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 203
TABLE 192 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 203
TABLE 193 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 203
TABLE 194 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 204
TABLE 195 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 205
TABLE 196 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 197 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 205
TABLE 198 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 206
TABLE 199 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 206
TABLE 200 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 207
TABLE 201 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 202 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 208
TABLE 203 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 208
TABLE 204 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 208
TABLE 205 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023–2030 (USD MILLION) 209
TABLE 206 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 207 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 210
TABLE 208 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 210
TABLE 209 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 211
TABLE 210 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, JANUARY 2022–MARCH 2025 213
TABLE 211 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION 217
TABLE 212 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGION FOOTPRINT 224
TABLE 213 CLOSED SYSTEM TRANSFER DEVICES MARKET: CLOSING MECHANISM FOOTPRINT 225
TABLE 214 CLOSED SYSTEM TRANSFER DEVICES MARKET: TYPE FOOTPRINT 226
TABLE 215 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPONENT FOOTPRINT 227
TABLE 216 CLOSED SYSTEM TRANSFER DEVICES MARKET: TECHNOLOGY FOOTPRINT 228
TABLE 217 CLOSED SYSTEM TRANSFER DEVICES MARKET: END-USER FOOTPRINT 229
TABLE 218 CLOSED SYSTEM TRANSFER DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 232
TABLE 219 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES, 2024 233
TABLE 220 CLOSED SYSTEM TRANSFER DEVICES MARKET: PRODUCT LAUNCHES A
ND APPROVALS, JANUARY 2021−MARCH 2025 234
TABLE 221 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEALS,
JANUARY 2021−MARCH 2025 234
TABLE 222 CLOSED SYSTEM TRANSFER DEVICES MARKET: EXPANSIONS, JANUARY 2021−MARCH 2025 235
TABLE 223 BD: COMPANY OVERVIEW 236
TABLE 224 BD: PRODUCTS OFFERED 237
TABLE 225 BD: EXPANSIONS, JANUARY 2021–MARCH 2025 238
TABLE 226 ICU MEDICAL, INC.: COMPANY OVERVIEW 240
TABLE 227 ICU MEDICAL, INC.: PRODUCTS OFFERED 242
TABLE 228 ICU MEDICAL, INC.: DEALS, JANUARY 2021–MARCH 2025 243
TABLE 229 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 244
TABLE 230 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 246
TABLE 231 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021–MARCH 2025 246
TABLE 232 B. BRAUN MELSUNGEN AG: EXPANSIONS, JANUARY 2021–MARCH 2025 247
TABLE 233 JMS CO. LTD.: COMPANY OVERVIEW 248
TABLE 234 JMS CO. LTD.: PRODUCTS OFFERED 249
TABLE 235 BAXTER: COMPANY OVERVIEW 250
TABLE 236 BAXTER: PRODUCTS OFFERED 251
TABLE 237 BAXTER: DEALS, JANUARY 2021–MARCH 2025 252
TABLE 238 WEST PHARMACEUTICAL SERVICES, INC: COMPANY OVERVIEW 253
TABLE 239 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED 255
TABLE 240 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS,
JANUARY 2021–MARCH 2025 255
TABLE 241 TERUMO CORPORATION: COMPANY OVERVIEW 256
TABLE 242 TERUMO CORPORATION: PRODUCTS OFFERED 257
TABLE 243 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2024 258
TABLE 244 CARDINAL HEALTH: COMPANY OVERVIEW 259
TABLE 245 CARDINAL HEALTH: PRODUCTS OFFERED 260
TABLE 246 EQUASHIELD: COMPANY OVERVIEW 261
TABLE 247 EQUASHIELD: PRODUCTS OFFERED 261
TABLE 248 EQUASHIELD: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021–MARCH 2025 262
TABLE 249 EQUASHIELD: DEALS, JANUARY 2021–MARCH 2025 262
TABLE 250 SIMPLIVIA HEALTHCARE LTD.: COMPANY OVERVIEW 263
TABLE 251 SIMPLVIA HEALTHCARE LTD.: PRODUCTS OFFERED 263
TABLE 252 SIMPLVIA HEALTHCARE LTD.: DEALS, JANUARY 2021–MARCH 2025 264
TABLE 253 YUKON MEDICAL: COMPANY OVERVIEW 265
TABLE 254 YUKON MEDICAL: PRODUCTS OFFERED 265
TABLE 255 CODAN MEDIZINISCHE GERÄTE GMBH: COMPANY OVERVIEW 266
TABLE 256 CODAN MEDIZINISCHE GERÄTE GMBH: PRODUCTS OFFERED 267
TABLE 257 VYGON: COMPANY OVERVIEW 268
TABLE 258 VYGON: PRODUCTS OFFERED 268
TABLE 259 VYGON: DEALS, JANUARY 2021–MARCH 2025 269
TABLE 260 ELCAM MEDICAL: COMPANY OVERVIEW 270
TABLE 261 ELCAM MEDICAL: PRODUCTS OFFERED 270
TABLE 262 PRACTIVET, INC.: COMPANY OVERVIEW 271
TABLE 263 PRACTIVET, INC.: PRODUCTS OFFERED 271
TABLE 264 CARAGEN: COMPANY OVERVIEW 272
TABLE 265 CORVIDA MEDICAL: COMPANY OVERVIEW 273
TABLE 266 VICTUS: COMPANY OVERVIEW 274
TABLE 267 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 275
TABLE 268 ERASER MEDICAL: COMPANY OVERVIEW 276
TABLE 269 NEEDLELESS CORPORATION: COMPANY OVERVIEW 277
TABLE 270 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW 278
TABLE 271 INSUNG MEDICAL CO., LTD.: COMPANY OVERVIEW 279
TABLE 272 ADVCARE MEDICAL, INC.: COMPANY OVERVIEW 280
TABLE 273 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD.: COMPANY OVERVIEW 280
LIST OF FIGURES
FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION
AND REGIONAL SCOPE 29
FIGURE 2 RESEARCH DESIGN 33
FIGURE 3 PRIMARY SOURCES 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 37
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 38
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 38
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 39
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF ICU MEDICAL, INC., 2024 40
FIGURE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION 41
FIGURE 10 CLOSED SYSTEM TRANSFER DEVICES MARKET: BOTTOM-UP APPROACH 41
FIGURE 11 CLOSED SYSTEM TRANSFER DEVICE MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH FOR US MARKET 42
FIGURE 12 CLOSED SYSTEM TRANSFER DEVICES MARKET: TOP-DOWN APPROACH 42
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2029 44
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
FIGURE 15 DATA TRIANGULATION METHODOLOGY 45
FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM,
2025 VS. 2030 (USD MILLION) 48
FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 49
FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT,
2025 VS. 2030 (USD MILLION) 49
FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 50
FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 51
FIGURE 21 GEOGRAPHIC SNAPSHOT OF CLOSED SYSTEM TRANSFER DEVICES MARKET 52
FIGURE 22 RISING INCIDENCE OF CANCER AND SUBSEQUENT USE OF CHEMOTHERAPY
TO DRIVE MARKET 53
FIGURE 23 DIAPHRAGM-BASED DEVICES SEGMENT AND JAPAN LED ASIA PACIFIC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2024 54
FIGURE 24 NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING
FORECAST PERIOD 55
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 55
FIGURE 26 CHINA TO GROW AT HIGHEST GROWTH CAGR DURING FORECAST PERIOD 56
FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
FIGURE 28 NEW REVENUE POCKETS FOR PLAYERS IN CLOSED SYSTEM TRANSFER
DEVICES MARKET 66
FIGURE 29 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES,
BY COMPONENT, 2022−2024 67
FIGURE 30 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES,
BY KEY PLAYER, 2022–2024 (USD) 68
FIGURE 31 AVERAGE SELLING PRICE OF CLOSED SYSTEM TRANSFER COMPONENTS,
BY REGION, 2022–2024 (USD) 69
FIGURE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET: VALUE CHAIN ANALYSIS 70
FIGURE 33 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 34 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 72
FIGURE 35 INVESTMENT AND FUNDING SCENARIO, 2019–2023 74
FIGURE 36 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 74
FIGURE 37 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 75
FIGURE 38 PATENT ANALYSIS, JANUARY 2015−MARCH 2025 79
FIGURE 39 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 82
FIGURE 40 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS,
BY COUNTRY, 2020–2024 83
FIGURE 41 PORTER’S FIVE FORCES ANALYSIS 94
FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES 97
FIGURE 43 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES 98
FIGURE 44 AI USE CASES 100
FIGURE 45 CLOSED SYSTEM TRANSFER DEVICE PRICING PER UNIT, BY VENDOR 105
FIGURE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 147
FIGURE 47 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 149
FIGURE 48 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT 175
FIGURE 49 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2020−2024 215
FIGURE 50 CLOSED SYSTEM TRANSFER DEVICES MARKET SHARE ANALYSIS OF
KEY PLAYERS, 2024 216
FIGURE 51 R&D EXPENDITURE OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2022 VS. 2023 217
FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS, 2025 218
FIGURE 53 EV/EBITDA OF KEY VENDORS 218
FIGURE 54 CLOSED SYSTEM TRANSFER DEVICES MARKET: BRAND/PRODUCT COMPARISON 219
FIGURE 55 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222
FIGURE 56 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY FOOTPRINT 223
FIGURE 57 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 231
FIGURE 58 BD: COMPANY SNAPSHOT (2024) 237
FIGURE 59 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 241
FIGURE 60 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2023) 245
FIGURE 61 JMS CO. LTD.: COMPANY SNAPSHOT (2024) 248
FIGURE 62 BAXTER: COMPANY SNAPSHOT (2024) 251
FIGURE 63 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2024) 254
FIGURE 64 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 257
FIGURE 65 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 260
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 高圧洗浄機市場 – 2030年までの世界予測 2025-06-12
- 装甲車両市場 – 2030年までの世界予測 2025-06-12
- 工業用ゴム市場 – 2030年までの世界予測 2025-06-12
- 追跡・トレースソリューション市場 – 2030年までの世界予測 2025-06-12
- エクソソーム研究市場 – 2030年までの世界予測 2025-06-10